Airway tissue engineering: An update

Jonathan M. Fishman, Katherine Wiles, Mark W. Lowdell, Paolo De Coppi, Martin J. Elliott, Anthony Atala, Martin A. Birchall

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Introduction: Prosthetic materials, autologous tissues, cryopreserved homografts and allogeneic tissues have thus far proven unsuccessful in providing long-term functional solutions to extensive upper airway disease and damage. Research is therefore focusing on the rapidly expanding fields of regenerative medicine and tissue engineering in order to provide stem cell-based constructs for airway reconstruction, substitution and/or regeneration. Areas covered: Advances in stem cell technology, biomaterials and growth factor interactions have been instrumental in guiding optimization of tissue-engineered airways, leading to several first-in-man studies investigating stem cell-based tissue-engineered tracheal transplants in patients. Here, we summarize current progress, outstanding research questions, as well as future directions within the field. Expert opinion: The complex immune interaction between the transplant and host in vivo is only beginning to be untangled. Recent progress in our understanding of stem cell biology, decellularization techniques, biomaterials and transplantation immunobiology offers the prospect of transplanting airways without the need for lifelong immunosuppression. In addition, progress in airway revascularization, reinnervation and ever-increasingly sophisticated bioreactor design is opening up new avenues for the construction of a tissue-engineered larynx. Finally, 3D printing is a novel technique with the potential to render microscopic control over how cells are incorporated and grown onto the tissue-engineered airway.

Original languageEnglish
Pages (from-to)1477-1491
Number of pages15
JournalExpert Opinion on Biological Therapy
Volume14
Issue number10
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Tissue Engineering
Tissue engineering
Tissue
Stem cells
Transplants
Stem Cells
Biocompatible Materials
Cytology
Stem Cell Factor
Regenerative Medicine
Expert Testimony
Bioreactors
Larynx
Prosthetics
Antigen-Antibody Complex
Research
Immunosuppression
Allografts
Cell Biology
Printing

Keywords

  • Airway management
  • Angiogenesis
  • Artificial organs
  • Biocompatible materials
  • Bioreactors
  • Larynx
  • Regenerative medicine
  • Stem cells
  • Tissue engineering
  • Tissue scaffolds
  • Trachea
  • Transplantation

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry
  • Drug Discovery

Cite this

Fishman, J. M., Wiles, K., Lowdell, M. W., De Coppi, P., Elliott, M. J., Atala, A., & Birchall, M. A. (2014). Airway tissue engineering: An update. Expert Opinion on Biological Therapy, 14(10), 1477-1491. https://doi.org/10.1517/14712598.2014.938631

Airway tissue engineering : An update. / Fishman, Jonathan M.; Wiles, Katherine; Lowdell, Mark W.; De Coppi, Paolo; Elliott, Martin J.; Atala, Anthony; Birchall, Martin A.

In: Expert Opinion on Biological Therapy, Vol. 14, No. 10, 01.01.2014, p. 1477-1491.

Research output: Contribution to journalArticle

Fishman, JM, Wiles, K, Lowdell, MW, De Coppi, P, Elliott, MJ, Atala, A & Birchall, MA 2014, 'Airway tissue engineering: An update', Expert Opinion on Biological Therapy, vol. 14, no. 10, pp. 1477-1491. https://doi.org/10.1517/14712598.2014.938631
Fishman JM, Wiles K, Lowdell MW, De Coppi P, Elliott MJ, Atala A et al. Airway tissue engineering: An update. Expert Opinion on Biological Therapy. 2014 Jan 1;14(10):1477-1491. https://doi.org/10.1517/14712598.2014.938631
Fishman, Jonathan M. ; Wiles, Katherine ; Lowdell, Mark W. ; De Coppi, Paolo ; Elliott, Martin J. ; Atala, Anthony ; Birchall, Martin A. / Airway tissue engineering : An update. In: Expert Opinion on Biological Therapy. 2014 ; Vol. 14, No. 10. pp. 1477-1491.
@article{a3435a1398f44fdca99fbf1822096ee5,
title = "Airway tissue engineering: An update",
abstract = "Introduction: Prosthetic materials, autologous tissues, cryopreserved homografts and allogeneic tissues have thus far proven unsuccessful in providing long-term functional solutions to extensive upper airway disease and damage. Research is therefore focusing on the rapidly expanding fields of regenerative medicine and tissue engineering in order to provide stem cell-based constructs for airway reconstruction, substitution and/or regeneration. Areas covered: Advances in stem cell technology, biomaterials and growth factor interactions have been instrumental in guiding optimization of tissue-engineered airways, leading to several first-in-man studies investigating stem cell-based tissue-engineered tracheal transplants in patients. Here, we summarize current progress, outstanding research questions, as well as future directions within the field. Expert opinion: The complex immune interaction between the transplant and host in vivo is only beginning to be untangled. Recent progress in our understanding of stem cell biology, decellularization techniques, biomaterials and transplantation immunobiology offers the prospect of transplanting airways without the need for lifelong immunosuppression. In addition, progress in airway revascularization, reinnervation and ever-increasingly sophisticated bioreactor design is opening up new avenues for the construction of a tissue-engineered larynx. Finally, 3D printing is a novel technique with the potential to render microscopic control over how cells are incorporated and grown onto the tissue-engineered airway.",
keywords = "Airway management, Angiogenesis, Artificial organs, Biocompatible materials, Bioreactors, Larynx, Regenerative medicine, Stem cells, Tissue engineering, Tissue scaffolds, Trachea, Transplantation",
author = "Fishman, {Jonathan M.} and Katherine Wiles and Lowdell, {Mark W.} and {De Coppi}, Paolo and Elliott, {Martin J.} and Anthony Atala and Birchall, {Martin A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1517/14712598.2014.938631",
language = "English",
volume = "14",
pages = "1477--1491",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Airway tissue engineering

T2 - An update

AU - Fishman, Jonathan M.

AU - Wiles, Katherine

AU - Lowdell, Mark W.

AU - De Coppi, Paolo

AU - Elliott, Martin J.

AU - Atala, Anthony

AU - Birchall, Martin A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Introduction: Prosthetic materials, autologous tissues, cryopreserved homografts and allogeneic tissues have thus far proven unsuccessful in providing long-term functional solutions to extensive upper airway disease and damage. Research is therefore focusing on the rapidly expanding fields of regenerative medicine and tissue engineering in order to provide stem cell-based constructs for airway reconstruction, substitution and/or regeneration. Areas covered: Advances in stem cell technology, biomaterials and growth factor interactions have been instrumental in guiding optimization of tissue-engineered airways, leading to several first-in-man studies investigating stem cell-based tissue-engineered tracheal transplants in patients. Here, we summarize current progress, outstanding research questions, as well as future directions within the field. Expert opinion: The complex immune interaction between the transplant and host in vivo is only beginning to be untangled. Recent progress in our understanding of stem cell biology, decellularization techniques, biomaterials and transplantation immunobiology offers the prospect of transplanting airways without the need for lifelong immunosuppression. In addition, progress in airway revascularization, reinnervation and ever-increasingly sophisticated bioreactor design is opening up new avenues for the construction of a tissue-engineered larynx. Finally, 3D printing is a novel technique with the potential to render microscopic control over how cells are incorporated and grown onto the tissue-engineered airway.

AB - Introduction: Prosthetic materials, autologous tissues, cryopreserved homografts and allogeneic tissues have thus far proven unsuccessful in providing long-term functional solutions to extensive upper airway disease and damage. Research is therefore focusing on the rapidly expanding fields of regenerative medicine and tissue engineering in order to provide stem cell-based constructs for airway reconstruction, substitution and/or regeneration. Areas covered: Advances in stem cell technology, biomaterials and growth factor interactions have been instrumental in guiding optimization of tissue-engineered airways, leading to several first-in-man studies investigating stem cell-based tissue-engineered tracheal transplants in patients. Here, we summarize current progress, outstanding research questions, as well as future directions within the field. Expert opinion: The complex immune interaction between the transplant and host in vivo is only beginning to be untangled. Recent progress in our understanding of stem cell biology, decellularization techniques, biomaterials and transplantation immunobiology offers the prospect of transplanting airways without the need for lifelong immunosuppression. In addition, progress in airway revascularization, reinnervation and ever-increasingly sophisticated bioreactor design is opening up new avenues for the construction of a tissue-engineered larynx. Finally, 3D printing is a novel technique with the potential to render microscopic control over how cells are incorporated and grown onto the tissue-engineered airway.

KW - Airway management

KW - Angiogenesis

KW - Artificial organs

KW - Biocompatible materials

KW - Bioreactors

KW - Larynx

KW - Regenerative medicine

KW - Stem cells

KW - Tissue engineering

KW - Tissue scaffolds

KW - Trachea

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84907055273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907055273&partnerID=8YFLogxK

U2 - 10.1517/14712598.2014.938631

DO - 10.1517/14712598.2014.938631

M3 - Article

AN - SCOPUS:84907055273

VL - 14

SP - 1477

EP - 1491

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 10

ER -